throbber
Vulebpege SCfEE"i5i'HJl
`
`Di5CLI55-EOE! BOETGS Create EH ACCOUM
`
`Community
`your Neulastam?
`
`B R EASTCANCE RDRG
`
`Search Breastcancer. org
`
`Search
`
`Home —- Treatment 8: Side Effects —- Hormonal Therapy — Selective Estrogen Receptor Modtilators (SERMS)
`
`Treatment ft Side Effects
`
`Day—to~Dav Matters
`
`Lower Your Risk
`
`Tamoxifen in Pill Form
`(Brand Name: Nolvadex]
`
`Tamoxifen in Liquid
`Form {Brand Name:
`Soltamox)
`
`<YNeulasta'
`yli-(_.-t-lora-.!ir\.
`
`Did you know there’s
`another way to get
`
`‘
`
`LEARN MORE >
`|.:S.-K-{I03-': ‘l T254
`
`'P‘=9‘‘i'—<''°‘*‘"‘¢%I
`
`Iii“ Neulasta
`
`Did you know there's
`another way to get
`you r Neulasta"?
`
`i
`
`’
`
`-
`
`S
`
`
`
`Email Updates
`Stay informed about current research. online
`events. and more.
`
`Email Address
`
`Sign Up
`
`Read ourgrivacvgolicv
`
`
`
`G.‘ Neulastaw
`..IifIii:]‘5"iiii"l'
`iv
`J
`There may be
`another way to
`
`A 1
`
`FIND OUT HOW )
`
`Willi’ '°'"”2*’1"ll-A""W5'*’=59"~"='1~'J5W°3 W5“
`
`DO N ATE TO
`BRE ASTCAN CERDHIE
`TO DAY!
`
`
`
`|nnoPharma Exhibit 1059.0001
`
`Evi sta
`
`FBFESIDH
`
`Selective Estrogen Receptor
`
`Modulators (SERMSJ
`
`IBRANéF‘~
`|]fiiiJCllJI!:!|iZl 23:.
`
`NEW — Expanded
`FDA approval.
`Ask your doctor
`about this
`
`innovative therapy.
`
`Fafisnt Produm lnfalmation
`
`. Anti-hi. by
`,
`.
`-
`._
`.
`urlnxlptlaii only.
`0%
`Scroll for lm portant Safety
`Information and Indications
`IBRANCE may cause
`serious side effects‘
`including:
`Low white blood cell counts
`[neutrapenia]. Low whiz
`o.:-od
`counts are very
`
`eed to deer: Your
`'|
`_
`.
`.
`ar-
`Full Frssaibing and
`
` .iLearn more
`
`0 0 3 pm“
`
`Selective estrogen receptor modulators, called SERMs for short, block the
`effects of estrogen in the breast tissue. SERMs work by sitting in the estrogen
`receptors in breast cells. If a SERM is in the estrogen receptor. there is no room
`for estrogen and it can't attach to the cell. it estrogen isn't attached to a breast
`cell, the cell doesn't receive estrogen‘s signals to grow and muitiply.
`
`Cells in other tissues in the body. such as bones and the Lnerus, also have
`estrogen receptors. But each estrogen receptor has a slightly different structure.
`depending on the kind of cell it is in. So breast cell estrogen receptors are
`different from bone cell estrogen receptors and both of those estrogen receptors
`are different from uterine estrogen receptors. As their name says, SERI-its are
`"selective" —this means that a SERM that blocks estrogen's action in breast
`cells can activate estrogen's action in other cells, such as bone, liver, and uterine
`cells.
`
`There are three SERMs:
`
`-
`
`tamoxifen in gill form (also called tamoxifen citrate; brand name: Nolvadex]:
`tamoxifen in liguid form (brand name: Soltamox}
`
`- Evista (chemical name: raloxifene]
`
`I Fareston (chemical name: toremifene)
`
`Each is a pill, usually taken once a day, except for tamoxifen in liquid form.
`Tamoxifen is the oldest. most well-known, and most-prescribed SERM.
`
`SERMS can be used to treat women both before and after menopause.
`
`Benefits of SERMS
`
`Because tamox ifen is the most commonly used SERM, most of the studies
`comparing SERMs to aromatase inhibitors have looked at tamoxifen versus
`aromatase inhibitors. Several studies have compared tamoxifen with aromatase
`inhibitors to see which type of medicine was more effective in treating early-
`stage, hormone—receptor—positive breast cancer in postmenopausal women.
`Based on the resuits, most doctors go by the following recommendations:
`
`- An aromatase inhibitor is the best type of hormonal therapy to start with for
`postmenopausal women. When treating early stage, hormone—rec eptor—
`positive breast cancer, aromatase inhibitors have more benefits and fewer
`serious side effects than tamoxifen.
`
`- Switching to an aromatase inhibitor after taking tamoxifen for 2 to 3 years (for
`a total of 5 years of hormonal therapy) offers more benefits than 5 years of
`tamoxifen. Taking an aromatase inhibitor for 5 years after taking tamoxifen for
`5 years continues to reduce the risk of the cancer coming back. compared to
`no treatment after tamoxifen.
`
`- Taking an aromatase inhibitor for 5 years after taking tamoxifen for 5 years
`continues to reduce the risk of the cancer coming back, compared to no
`treatment after tamoxifen.
`
`

`

`For premenopausal women diagnosed with hormone—receptor—posi'tive breast
`cancer, the SERM tamoxifen is the hormonal therapy treatment standard.
`
`Side effects of SERMS
`
`SERMS may cause some serious side effects, including blood clots, Q, and
`endometrial cancer. If you and your doctor are considering tamoxifen or another
`SERM as part ofyour treatment plan, tell your doctor ifyou smoke or have a
`history of blood clots or heart attack. If you're taking a SERM. call your doctor
`immediately if you have any of these symptoms:
`
`- abnormal vaginal bleeding or discharge
`
`0 pain or pressure in the pelvis
`
`-
`
`leg mg or tenderness
`
`I chest pain
`- shortness of breath
`
`- weakness, tingling, or numbness in your face. arm, or leg
`
`- sudden dirfficum seeing
`- dizziness
`
`- sudden severe headache
`
`The most common side effects of SERMs are:
`
`fatigue
`-
`- hotflashes
`
`- night sweats
`
`- vaginal discharge
`
`- mood swings
`
`You should not take a SERM ifyou are breastfeeding. pregnant. trying to get
`pregnant, or ifthere is any chance that you could be pregnant. These medicines
`may cause damage to developing embryos. You should use an effective non-
`hormonaltype of birth control —— such as condoms. a diaphragm along with
`spermicide. or a non—hormonal |.U.D. —while you are taking a SERM. Ask your
`doctor which type of non—hormonal birth control would be best for you, as well as
`how long you should use this type of birth control after you stop taking a SERM‘.
`
`As a benefit, SERMs also can improve bone density. which reduces the risk of
`osteoporosis.
`
`Last modified on November 5_, 2915 at '."l.'5O AM
`Leer esta pagina en espafiol
`
`More From Our Site
`
`Rec omroen also by Ftlyz.‘ 1.32.? :r‘u
`
`Estrogen Receptor
`Downregulators [ERDs]
`
`Honnonal Therapy side
`Effects comparison
`Chart
`
`Symptoms 8. Iliagnosis
`
`Back to To L
`
`Breastc ancer. org is a non-profit organization dedicated to providing information and cornmunfty to those
`touched by this disease. Learn more about
`'
`"
`
`Stay lnfonned about current research, online
`events. and more.
`
`f
`
`Eireastcancerorg ‘l2[l East Lancaster Avenue: Suite 2[]1 Ardmore PA 19003
`© 2016 Breastcancer. org - All rights reserved.
`
`.3’!
`" \ cunnitiviiunvienton
`
`Email address
`
`Sign up
`
`Learn more about ;"_A
`
`|nnoPharma Exhibit 1059.0002
`
`

`

`Fa ur Star [Hm nu
`
`
`
`htln:.-Iwweub1995152noe'.Dng."t:ea1-‘nerlt-no"nana‘-same F"‘.JiJ|'I
`
`III 2-‘J16 15:53:33 GV."’a'—$IT-’.Il{| :F'ac'f?c Day-zzghl Tr-re]
`
`|nnoPharma Exhibit 1059.0003
`
`

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket